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INTRODUCTION
In response to DNA double-strand breaks (DSBs), the histone H2A variant H2AX is rapidly phosphorylated by the phosphatidylinositol(3) kinase-like kinases ATM, DNA-PKcs and ATR (ataxia telangiectasia mutated, DNA-dependent protein kinase catalytic subunit and ataxia telangiectasia and Rod3 related, respectively) to form gH2AX (Rogakou et al, 1998) . This phosphorylation event produces a large chromatin domain of up to 1 Mb surrounding DNA lesions, which acts as a signal for the recruitment and accumulation of DNA repair and signalling proteins (Rogakou et al, 1999; Celeste et al, 2003) . For example, the checkpoint mediator MDC1 (mediator of DNA damage checkpoint 1) binds to gH2AX directly through an interaction between the MDC1 tandem BRCT domains and an H2AX epitope encompassing phosphoserine 139 and its free carboxyl terminus (Stucki et al, 2005) . The gH2AX-MDC1 complex, in turn, promotes the recruitment of many proteins such as 53BP1 (tumour protein p53-binding protein 1), NBS1 (Nijmegen breakage syndrome 1), RNF8 (ring-finger protein 8) and BRCA1 (breast cancer 1 early onset) to mediate DNA repair and checkpoint signalling (Harper & Elledge, 2007) .
Although the formation of gH2AX and its role in promoting protein recruitment to the sites of DNA damage are becoming increasingly understood, much less is known about how and why it is removed from chromatin once DNA repair has been effected. The removal of gH2AX from sites of DNA damage is evidently tightly regulated, as it is closely correlated with DNA repair. Mechanisms must therefore exist to restrict gH2AX to sites of DNA lesions. These systems most likely comprise phosphatases that erase the gH2AX histone marker and histone/nucleosome remodelling activities that remove gH2AX from sites of DNA damage (Linger & Tyler, 2007) . How these two processes integrate together is so far not understood.
Work in budding yeast recently identified the product of the PPH3 gene as the sole gH2AX phosphatase in this organism (Keogh et al, 2006) . Pph3 encodes the orthologue of the mammalian PP4 phosphatase catalytic subunit (PP4C; Cohen et al, 1990; Ronne et al, 1991; Brewis et al, 1993) . The yeast PP4 complex does not seem to have a direct function in DNA repair but rather acts to couple DSB repair with termination of checkpoint signalling, a process commonly referred to as checkpoint recovery (Keogh et al, 2006) . The role of Pph3 in checkpoint recovery is at least in part due to its function as a gH2AX phosphatase, as the delay in checkpoint recovery manifested by pph3D cells is largely alleviated by the expression of a nonphosphorylatable H2A mutant (Keogh et al, 2006) . Taken together, these results indicate that the formation of the gH2AX chromatin domain and its dissolution are important in the control of checkpoint signalling. By contrast, recent work in human cells attributed the function of gH2AX phosphatase to PP2A rather than PP4 (Chowdhury et al, 2005) , raising doubts about the function of PP4 in the dephosphorylation of gH2AX in species other than yeast.
Here, we address directly whether PP4 contributes to the dephosphorylation of gH2AX in human cells. First, we show that immunopurified PP4 readily dephosphorylates gH2AX in vitro. Depletion of PP4C by RNA interference in cycling or irradiated cells results in increased steady-state levels of gH2AX. Furthermore, depletion of PP4C slows down the turnover of gH2AX after the pharmacological inhibition of ATM and DNA-PK, indicating that PP4C is a physiological gH2AX phosphatase. Consistent with this idea, depletion of PP4C results in persistent gH2AX focipositive cells, suggesting that PP4 acts at the sites of DNA damage. Intriguingly, dissolution of gH2AX foci in PP4C-depleted cells is nevertheless observed 6 h post-irradiation despite the persistence of phosphorylated H2AX in the chromatin fraction. These results indicate that PP4 counteracts gH2AX not only at the sites of DNA damage but also in undamaged chromatin. Finally, we observe a checkpoint recovery defect associated with the depletion of PP4C, suggesting that PP4 has a function in the termination of checkpoint signalling. Taken together, these results indicate that PP4 is an authentic gH2AX phosphatase important for the spatio-temporal regulation of the DNA damage checkpoint.
RESULTS AND DISCUSSION
Immunopurified PP4 and PP2A dephosphorylate cH2AX
In yeast, Pph3 encodes the yeast orthologue of human PP4C, which is part of a protein complex composed of Pph3, Psy2 and Psy4 (Gavin et al, 2002; Ho et al, 2002; Gingras et al, 2005) . This complex is conserved in human cells and contains, in addition to PP4C, the PP4R2 and PP4R3 regulatory subunits. As PP2A rather than PP4 has been implicated as a mammalian gH2AX phosphatase, we sought to determine whether human PP4 can also dephosphorylate gH2AX. First, we tested whether purified PP4 dephosphorylates gH2AX in vitro. For this purpose, we acid-extracted histones from U2OS cells irradiated with a dose of 100 Gy to obtain histone preparations enriched in gH2AX (supplementary Fig S1 online) . As a source of phosphatases, we immunopurified epitope-tagged PP1C, PP2ACa, PP4C or the catalytically inactive PP4C-H56Q and PP4C-R86A mutants from stably transfected 293 cells where the expression of epitopetagged PP2ACa and PP4C was found to be near wild-type levels (supplementary Fig S2 online) . We opted to immunopurify protein phosphatase complexes rather than to purify free catalytic subunits to retain as much as possible the subunit composition of the PP2A and PP4 holoenzyme complexes. This approach is important to minimize a well-known loss of substrate specificity seen with isolated catalytic subunits (Tung et al, 1985) , as their regulatory proteins allow the Ser/Thr phosphatases to interact with various targets under appropriate regulation. By using the criterion of activity against 6,8-difluoro-4-methylumbelliferyl phosphate, all wild-type phosphatase complexes were found to be active, whereas the catalytically inactive PP4C mutants had negligible activity (supplementary Fig S2 online) . As shown in Fig 1, PP2ACa can readily dephosphorylate gH2AX, as reported previously (Chowdhury et al, 2005) . Furthermore, PP4C-but neither PP1 nor the PP4C phosphatase-dead mutants-also robustly dephosphorylates gH2AX in a dose-dependent manner (Fig 1A-C) . Finally, we immunoprecipitated epitope-tagged PP4R2, the orthologue of yeast Psy4, as a means of immunopurifying PP4C in complex with regulatory subunits. As shown in Fig 1D, immunoprecipitates of PP4R2 are able to dephosphorylate gH2AX robustly to a level that is at least equivalent to immunopurified PP4C. From these results, we conclude that PP4C acts as a gH2AX phosphatase in vitro.
PP4 and PP2A counteract phosphorylation of H2AX Next, we examined the impact of PP4C and PP2AC depletion on the total levels of gH2AX. We transfected small interfering RNA (siRNA) duplexes to deplete PP4C or PP2AC from U2OS cells (Fig 2A) . As PP2AC is encoded by two genes in the human genome, giving rise to two proteins-a and b-that are 97% identical to each other (Zhou et al, 2003) , our targeting duplexes PP4 is a gH2AX phosphatase S. Nakada et al were designed to silence the expression of both proteins. Using this strategy, siRNA-mediated depletion of PP4C and PP2ACa/b in U2OS cells decreased the levels of both catalytic subunits to about 20% of the control levels. Levels of gH2AX were estimated by immunoblotting before or 1-8 h after a 10 Gy dose of X-rays. As shown in Fig 2A, depletion of PP4C and PP2AC each resulted in a marked increase in the total levels of gH2AX in both nonirradiated and irradiated cells. To control for off-target effects, we repeated the experiment using other siRNAs and obtained similar results (supplementary Fig S3 online) . Depletion of PP4R2 also resulted in an increase in the total levels of gH2AX (Fig 2B) , placing PP4R2 as part of a PP4C-containing complex that regulates the levels of gH2AX in human cells. Furthermore, irradiation of cells with a 10 Gy dose of X-rays did not induce 2 h 4 h 8 h P P 2 A C P P 4 C C o n t r o l P P 2 A c P P 4 C C o n t r o l P P 2 A C P P 4 C C o n t r o l 9 8 7 6 5 4 3 2 1 Lane
Control siRNA 0.3 h 6 h P P 2 A C C o n t r o l P P 4 C P P 2 A C C o n t r o l P P 4 C P P 2 A C C o n t r o l C o n t r o l P P 4 C P P 4 C P P 2 A C 6 h 2 h 0. No IR 1 h 2 h 4 h 8 h P P 4 R 2 C o n t r o l P P 4 R 2 C o n t r o l P P 4 R 2 C o n t r o l P P 4 R 2 C o n t r o l P P 4 R 2 C o n t r o l Tail moments for each condition were calculated on a minimum of 75 cells for each data point, normalized against the average comet tail moment of the mock-irradiated control, and shown as a box-andwhisker plot. Outliers are indicated as dots. The ordinate is a square-root scale. Data were statistically analysed using the Wilcoxon test. P-values are adjusted for several comparisons with the Bonferroni method. *Po0.05; **Po0.01; ***Po0.0001; NS, no significance. (E) U2OS cells transfected with siRNAs against either PP4C or a control sequence were irradiated with 10 Gy. At 1 h post-IR, the ATM (KU55933) and DNA-PK (KU57788) inhibitors were added to the tissue culture medium (t ¼ 0). Samples were then collected at the indicated time points and processed for immunoblotting with the indicated antibodies. Signal intensity was analysed using Image-J. Signal intensity of gH2AX is normalized against that of histone H3. ATM, ataxia telangiectasia mutated; DNA-PK, DNA-dependent protein kinase; H3, histone H3; IR, irradiation; siRNA, small interfering RNA.
PP4 is a gH2AX phosphatase S. Nakada et al rapid apoptosis in PP4C-and PP2AC-depleted cells, suggesting that the persistence of gH2AX was independent of apoptosis (supplementary Fig S4 online) . To test whether this increase in phosphorylation was due to lingering DSBs imparted by a DNA repair defect, we examined DSB rejoining kinetics in control, PP2AC-and PP4C-depleted cells by neutral comet assays. As shown in Fig 2C,D, PP2AC -silenced cells are mildly impaired in the repair of X-ray-induced DSBs, which is consistent with the previously described function of PP2AC in the repair of camptothecin-induced lesions (Chowdhury et al, 2005) . By 
PP4 participates in the dephosphorylation of H2AX
PP2A-type enzymes have been linked to gH2AX through the regulation of ATM activity (Goodarzi et al, 2004) . Therefore, we sought to test whether PP4 acts directly on gH2AX or indirectly by promoting the activity of ATM or DNA-PK, the two main H2AX kinases (Stiff et al, 2004) . For this purpose, we examined the turnover of gH2AX after the combined inhibition of ATM and DNA-PK. In preliminary studies, we found that a combination of the ATM inhibitor KU55933 and the DNA-PKcs inhibitor (DNA-PKi) KU57788 suppressed the irradiation-induced formation of gH2AX (supplementary Fig S5 online) . Therefore, we treated siRNA-transfected cells with both inhibitors 60 min postirradiation to inhibit the phosphorylation of H2AX, and monitored the decay of gH2AX by immunoblotting. Using this experimental scheme, depletion of PP4C resulted in slower kinetics of H2AX dephosphorylation (Fig 2E) . These results indicate that PP4C can bring about dephosphorylation of H2AX in vivo, independently of an effect on ATM and DNA-PK.
PP4 dephosphorylates cH2AX at the sites of DNA lesions
To identify the pools of gH2AX targeted by PP4, we assessed the kinetics of gH2AX focus formation and dissolution by indirect immunofluorescence (Fig 3A) . To support the gH2AX data, we also examined MDC1 foci dynamics, as the recruitment of MDC1 to DSB sites occurs through a direct interaction with gH2AX (Stucki et al, 2005 ; Fig 3B) . MDC1 foci therefore represent a functional readout of gH2AX at DSB sites. In contrast to the result shown in Fig 2A, gH2AX foci diminished rapidly in both PP4C-and PP2AC-depleted cells (Fig 3A) . However, as shown in Fig 3A and quantified in Fig 3C, PP4C -depleted cells showed a slower decrease in gH2AX foci-positive cells than control-transfected cells during the recovery from irradiation, whereas depletion of PP2AC did not affect gH2AX foci kinetics. The slower dissolution of gH2AX foci in PP4C-depleted cells was observed with a second independent siRNA (Fig 3D) and was rescued by the introduction of an siRNA-resistant PP4C cDNA (supplementary Fig S6 online) , confirming the specificity of the phenotype. In addition, MDC1 foci dynamics closely matched those of the gH2AX foci (Fig 3B,E) . We also examined the dissolution of irradiation-induced gH2AX foci after the addition of the ATM (KU55933) and DNA-PK (KU57788) inhibitors to exclude the possibility that depletion of PP4 results in an increase in the activity of ATM or DNA-PK. As shown in Fig 3F, we found that the depletion of PP4C slowed the rapid dissolution of gH2AX foci. Finally, we present as supplementary information online data examining gH2AX focus morphology in PP4-depleted cells that are also consistent with a delay in focus dissolution (supplementary Fig S7 online) . From these observations, we conclude that PP4 could dephosphorylate gH2AX at the sites of DNA damage, whereas PP2A might not have a principal function at these sites after treatment with irradiation. However, other mechanisms must also be important to remove this histone marker from the chromatin that surrounds the DSB.
Dephosphorylation of H2AX occurs in chromatin
The persistence of irradiation-induced phosphorylation of H2AX in PP4-or PP2A-depleted cells, as detected by immunoblotting (Fig 2) , conflicts with our observation that dissolution of gH2AX foci still occurs in those cells, despite being slowed in the case of PP4. As the removal of gH2AX from repaired chromatin is most likely to be the result of the combined action of phosphatases and histone exchange (Heo et al, 2008) , we assessed whether the lingering gH2AX observed in PP4-depleted cells is found in the nucleoplasm or associated with the chromatin after cell fractionation (Méndez & Stillman, 2000) . We monitored the distribution of histone H3 to estimate nucleosome eviction or exchange. In the absence of irradiation, neither histone H3 nor gH2AX was detected in the nuclear soluble fraction of control-transfected cells (supplementary Fig S8 online) . After irradiation, or in PP4C-depleted cells, we observed an increase in gH2AX and histone H3 in the soluble fraction, suggesting that gH2AX stimulates histone exchange, as recently shown (Fig 3G; Heo et al, 2008) . Nevertheless, we found that most of the persistent gH2AX seen in PP4C-depleted cells remained associated with the chromatin fraction, despite the detectable increase in histone exchange or eviction (Fig 3G) . On the basis of these results, we conclude that PP4 dephosphorylates gH2AX primarily in the chromatin rather than in the nucleoplasm. A surprising corollary to these results is that recycling gH2AX into chromatin might be an important step before its dephosphorylation. Indeed, as extensive chromatin remodelling and nucleosome eviction occurs during DSB repair, we propose that cells might have co-opted this process to promote the rapid removal of gH2AX and dephosphorylation.
PP4 promotes recovery from the G2/M checkpoint arrest
The observation that focused dissolution of MDC1 is slowed after the depletion of PP4C suggests that PP4 might antagonize checkpoint signalling by stimulating focus disassembly at the sites of DNA damage. This possibility echoes the situation in yeast, in which Pph3 promotes G2/M checkpoint recovery (Keogh et al, 2006) . Therefore, we established a system that monitors recovery (G) U2OS cells transfected with siRNAs against PP4C or a control sequence were collected at the indicated time points immediately before (no IR), or 1 or 6 h after irradiation (10 Gy), then fractionated as described in Méndez & Stillman (2000) into whole-cell lysates (WCLs), nuclear soluble (S3) or chromatin (P3) fractions, and analysed by immunoblotting using the indicated antibodies. DAPI, 4,6-diamidino-2-phenylindole; H3, histone H3; IR, irradiation; MDC1, mediator of DNA damage checkpoint 1; siRNA, small interfering RNA.
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PP4 is a gH2AX phosphatase S. Nakada et al from the G2/M arrest after irradiation treatment (Fig 4A) . By using this experimental scheme, we find that the percentage of phosphohistone H3-positive cells 1 h post-irradiation is comparable among control and PP4C siRNA-transfected cells, indicating that PP4 is not involved in the initiation of the G2/M checkpoint (Fig 4B,C) . However, at later time points, we observed that control cells began entering mitosis 7 h post-irradiation, whereas PP4C-depleted cells began entering mitosis more than 9 h after the initial arrest (Fig 4D; supplementary Fig S9 online) . Seen from another angle, at the 8 h post-irradiation time point, PP4C-depleted cells showed a 3.3-fold reduction in the number of cells that entered mitosis (Fig 4B,C) . These data indicate that PP4 has an important and evolutionarily conserved function during recovery from checkpoint arrest. PP4 is a gH2AX phosphatase S. Nakada et al
In conclusion, our results indicate that PP4 is a gH2AX phosphatase in human cells that acts on gH2AX not only at chromatin surrounding DNA damage but also at intact chromatin and that it is required for recovery from the DNA damage checkpoint (Fig 4E) . The function of PP4 in the dephosphorylation of gH2AX is therefore evolutionarily conserved, whereas that of PP2A seems to have been acquired during eukaryotic evolution (or lost by budding yeast). We made the surprising observation that PP4 and PP2A do not act redundantly. PP4 dephosphorylates gH2AX at irradiation-induced DSBs, whereas PP2A has a minimal function at those sites. Our finding conflicts with a previously published report (Chowdhury et al, 2005) , in which PP2AC-depleted cells showed persistent gH2AX foci after treatment with camptothecin (a topoisomerase I inhibitor). Here, we note the possibility that PP4 and PP2A might respond to different types of DNA damage. In addition, the delayed kinetics of dissolution of gH2AX foci, which was seen by Chowdhury et al (2005) in PP2AC-depleted cells, could also simply be due to the observed DNA repair defect. Future work will be aimed at deciphering whether PP4 and PP2A have distinct functions in the turnover of H2AX phosphorylation and also how they cooperate with the chromatin remodelling processes that act at the sites of DNA damage to control the DNA damage response.
METHODS
RNA interference. All siRNA transfections were performed using Dharmafect 1 (ThermoFisher; Waltham, MA, USA). All experiments were performed from 32 to 48 h post-siRNA transfection; siRNA sequences are described in the supplementary information online. Western blotting. Nitrocellulose membranes were stained with mouse anti-gH2AX (Upstate; Temecula, CA, USA; clone JBW301, at 1:5000 dilution in 3% BSA in PBS), rabbit anti-PP4C (Bethyl; Montgomery, TX, USA; A300-835A, 1:4000), rabbit anti-PP4R2 (Bethyl; A300-838A, 1:2000), mouse anti-PP2AC (BD Biosciences; San Jose, CA, USA; clone 46, 1:2000) and rabbit anti-histone H3 (Abcam; Cambridge, UK; ab1791, 1:20,000). Immunofluorescence. U2OS human osteosarcoma (ATCC HTB-96) cells were grown on glass coverslips, fixed with methanol at À20 1C, and then permeabilized with acetone at À20 1C. Blocking, incubations with mouse anti-gH2AX (1:10,000; Upstate; clone JBW301), sheep anti-MDC1 (1:1000; AbD Serotec; AHP799) and secondary antibodies and washes were carried out in ADB (3% normal goat serum, 0.1% Triton X-100 in PBS). DNA was counterstained with 4,6-diamidino-2-phenylindole and coverslips were mounted with Prolong Gold (Invitrogen; Eugene, OR, USA). Images were taken using a Leica DMIRE2 microscope equipped with a Â 63 oil immersion objective, or a Zeiss Axiovert200M microscope equipped with a Â 20 objective or Â 40 water immersion objective, a CSU10 spinning disc confocal unit (Yokogawa; Tokyo, Japan) and a C9100-12 camera (Yokogawa) using Volocity software (Improvision; Coventry, UK). G2/M checkpoint recovery assay. Cells were first exposed to 5 mg/ml aphidicolin, a DNA polymerase inhibitor, to prevent progression to S phase. Next, cells were irradiated with a dose of 3 Gy, and 1 h post-irradiation 100 ng/ml nocodazole was added to the media to capture cells entering mitosis. Cells were fixed with 2% paraformaldehyde at various time points, permeabilized with 90% methanol and blocked with fluorescence-activated cell sorting incubation buffer (0.5% BSA in PBS) for 10 min. Cells were then stained with anti-phospho-histone H3 (Ser 10) and fluorescein isothiocyanate-conjugated donkey anti-mouse IgG (Jackson ImmunoResearch; West Grove, PA, USA) and counterstained with propidium iodide (Sigma-Aldrich; St Louis, MO, USA). More than 10,000 cells per condition were analysed by flow cytometry (FACSCalibur; Becton Dickinson; Franklin Lakes, NJ, USA). Data were analysed by Cell Quest Pro (Becton Dickinson). Phosphatase assays. For histone dephosphorylation, eluted phosphatases were first preincubated in 35 ml of reaction buffer (50 mM Tris-Cl pH 7.2, 0.1 mM CaCl 2 , 5 mM MnCl 2 and 0.2 mg/ml BSA) for 10 min at 30 1C. Acid-extracted histones were then added and phosphatase reactions were incubated at 30 1C for 1 h. Neutral comet assay (single-cell gel electrophoresis). Neutral comet assays were performed on cells exposed to a dose of 50 Gy X-ray. Assays were carried out using the Comet Assay system (Trevigen; Gaithersburg, MD, USA), according to the manufacturer's instructions with a minor modification: samples were treated with RNaseI and stained with propidium iodide. In total, 75 cells were analysed per sample using Scion Image with the comet assay macro, scion_comet1.3 (Helma & Uhl, 2000) for comet tail moment. Supplementary information is available at EMBO reports online (http://www.emboreports.org).
